Skip to main content

Table 3 Change in plasma total C1q value from pre-dose to 24 h post-dose in healthy volunteer subjects by cohort (single dose, SAD)

From: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial

Cohort

Number of subjects (N)

C1q (mcg/ml) median change (± SD)

P-value

placebo

8

-2 (± 12)

NS

2 mg/kg

6

-2 (± 7)

NS

10 mg/kg

6

0 (± 8)

NS

40 mg/kg

6

 + 5 (± 11)

NS

120 mg/kg

6

 + 18 (± 7)

0.004

  1. NS not significant